Delivery Order SPE2DR25D3013-SPE2DR26F6V7B
Award Date 12/29/25
Potential Completion Date 1/21/26
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $14,218.46 to AmerisourceBergen Drug Corp for 90 tablets of Lumakras 320 mg on December 1, 2025, with completion scheduled for December 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a pharmaceutical supply delivery to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $13,491.97 to AmerisourceBergen Drug Corp for the supply of Lumakras 120 mg tablets (240 count). The contract, awarded on October 17, 2025, with an ultimate completion date of November 7, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,491.97 to AmerisourceBergen Drug Corp for the supply of Lumakras 320 mg tablets (90-count units) under a firm fixed price contract type. The award was issued on August 29, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Lumakras 320 mg tablets in a quantity of 90 units, with a ceiling value of $14,218.46. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 2, 2026, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a pediatric medication...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Lumakras 320 mg tablets (90-unit quantity) with a ceiling value of $14,218.46. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by November 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $13,304 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562327556 LUMAKRAS 320 MG tablets. As the prime contractor, Amerisourcebergen will deliver 90 tablets to a facility in Conshohocken, Pennsylvania, under a contract running from September 27 to October 19, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency functions to provide logistics support to the Department of...
- The Defense Logistics Agency Troop Support Medical awarded a $12,042.18 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg tablets of LUMAKRAS in 240 count bottles. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support DLA Troop Support Medical programs. No major subcontractors or set aside designations were identified. This delivery order was issued on the agency's...
- The Defense Logistics Agency awarded a $13,119.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lazcluze 80 mg on December 22, 2025, with completion targeted for January 14, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,191.22 for 30 tablets of Mekinist 2 mg on December 23, 2025, with an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement of the oncology medication and contains no subcontractor information. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $117,041.96 by the Defense Logistics Agency (DLA) on November 17, 2025, with an ultimate completion date of December 9, 2025. The contract, which is not set-aside and was competitively awarded, involves the supply of BRUKINSA 160 mg tablets (60-count), a specialized pharmaceutical product supporting federal medical procurement needs. This delivery...